Patent ID: 6541014
Filing Date: 2003-04-01
Classification: A61K

Abstract:
A once-a-day antiviral product comprising: first, second, and third antiviral dosage forms, each of said antiviral dosage forms comprising at least one antiviral and a pharmaceutically acceptable carrier, said first antiviral dosage form being an immediate release dosage form, said second and third antiviral dosage forms being delayed release dosage forms, and wherein each of said first, second, and third antiviral dosage forms initiates release of said at least one antiviral at different times, said once-a-day antiviral product further comprising a therapeutically effective amount of said at least one antiviral, said therapeutically effective amount being the total dosage of said at least one antiviral for a twenty-four hour period, and wherein said at least one antiviral released by said once-a-day antiviral product achieves Cmax in serum in less than twelve hours after administration.